Comparison 39. AbobotulinumtoxinA 60 units versus placebo one cycle of treatment in glabellar lines.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
39.1 Participant assessment of success by analysing scores and scales | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
39.1.1 4 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
39.2 Physician assessment of success by analysing scores and scales | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
39.2.1 4 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected |